Follow-up With Preimplantation Genetic Testing Patients

NCT04477863 · tracked via the Priya Life Science USA tracker

Sponsor

Genomic Prediction Inc.

Phase

Observational

Started

2020-07-11

Last updated

2025-08-26

Condition(s) studied

InfertilityGenetic DiseaseIVF

Investigational drug(s) / intervention(s)

Follow-up Interview

Follow-up Interview: Non Applicable

Study summary

The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients indicating willingness to participate in research during informed consent to perform PGT Exclusion Criteria: * Patients who opted out of participating in research during informed consent to perform PGT

Primary outcome measure(s)

Patient perspectives on PGT — 2 years
Analysis of interview responses

Trial sites (1)

Facility	City	Region	Status
Genomic Prediction Clinical Laboratory	North Brunswick	New Jersey	Recruiting

More Genomic Prediction Inc. trials in the USA

ANXA5 M2 Haplotyping in IVF Patients and Embryos Active, not recruiting

Cell Free Preimplantation Genetic Testing Starting soon

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial Recruiting

Preimplantation Genetic Testing in Women of Advanced Maternal Age Recruiting

Other trials for the same condition

ANXA5 M2 Haplotyping in IVF Patients and Embryos Active, not recruiting

Aspire In Vitro Maturation Study Enrolling by invitation

Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing Enrolling by invitation

Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer Recruiting

To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles. Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04477863 on ClinicalTrials.gov ↗ ← All trials in the USA